Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Inv. presentation
Director departure
Quarterly results
|
|
Protalix BioTherapeutics, Inc. (PLX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2022 |
3
| Ben Zvi Shmuel (Director) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 02/16/2021 |
3
| Dexcel Pharma Technologies Ltd. (10% Owner) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 07/08/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/03/2020 |
3
| Melincoff Gwen A (Director) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 01/03/2020 |
3
| Boudes Pol F (Director) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 09/24/2019 |
3
| Rubin Eyal (Sr. VP & CFO) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 07/02/2019 |
3
| Bashan Dror (President & CEO) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 08/13/2018 |
3
| Granot David (Director) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 06/08/2018 |
3
| Naos Yaron (Sr. VP, Operations) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 09/07/2010 |
3
| Palash Tzvi (COO) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
| 12/23/2009 |
3
| Lauterbach Sandra Leigh (VP, Sales & Commercial Affairs) has filed a Form 3 on Protalix BioTherapeutics, Inc. |
|
|